RBC cuts Methanex stock price target on easing Iran tensions

RBC Capital cut its Methanex (MEOH) price target to $65 from $70 (Sector Perform) on expectations that methanol prices/EBITDA peaked in Q2 2026 and will normalize through 2H 2026 into early 2027, while noting easing Iran-related Strait of Hormuz tensions. The stock is $4.73 (~52% below the 52-week high) but up 85% over six months, with additional catalysts tied to potential buybacks starting in 2H 2026 and plant idling of 860,000 tonnes/year Titan capacity in Trinidad and Tobago beginning in 3Q 2026. Overall, the article highlights a split of higher targets from peers (e.g., Scotiabank to $80, BMO to $75) versus JPMorgan downgrading to Neutral over valuation concerns, implying limited near-term clarity on fundamentals.

Analysis

The real read-through is not the analyst target cut; it is that MEOH is being repriced as a highly convex exposure to the methanol/natural gas spread, not a steady industrial. A near-term supply interruption in a basin that matters for Atlantic pricing can keep realized prices elevated even if the geopolitical risk premium fades, but that support is fragile because the stock has already absorbed a large portion of the bullish narrative over the past six months.

Second-order, the likely winners are downstream users with the ability to pass through input costs and competitors with cheaper feedstock positions; the losers are methanol-intensive chemical chains and any alternative-fuel thesis that depends on cheap methanol. Titan’s idling matters more than the headline easing in shipping risk because it removes physical supply, but that same tightness also raises the odds of demand destruction, inventory drawdowns, and rapid substitution if prices stay elevated into late summer.

Consensus appears too comfortable treating buybacks as a floor. For a levered name with weak balance-sheet optics, capital returns are usually lagging confirmation, not first-order support, so the equity can still de-rate if Q3 realized pricing rolls over. The key falsifier is simple: if realized methanol prices and EBITDA stay near Q2 levels through the Titan outage window, the bear case is wrong; if they normalize faster than expected, the current rally likely mean-reverts over 1-3 months.

Key Decisions for Investors

• Do not chase MEOH here; wait for either a pullback or clear confirmation that Q3 realized methanol prices are staying elevated after the Titan idling date. Risk/reward is poor after an 85% six-month move unless the supply shock proves durable.
• If already long MEOH, tighten risk with short-dated puts or a partial trim into strength ahead of the Q3 contract-expiry / idling window. The stock is likely to give back a meaningful portion of the move if methanol benchmarks soften.
• Relative-value expression: long MEOH vs short XLB on a 1-3 month horizon only if methanol posted prices remain firm into the next pricing update. This isolates commodity tightness from broad chemical beta; exit if July/August pricing rolls over.
• Treat announced buybacks as a confirmation event, not a catalyst. Add only if management brings forward repurchases with visible free-cash-flow acceleration; otherwise assume buyback support is too delayed to offset a commodity reversal.